Mumbai lab develops home sperm-test kit
- BRICS LIVE: PM Modi holds talks with Russian President Vladimir Putin on opening day
- Chinese state media slams West's 'bad mouthing' of BRICS
- Delegitimise all terror groups operating on your soil, US tells Pakistan
- Two men charged with hate crime in attack on Sikh in California
- Army won’t forgive if we sleep when we should be awake: PM Narendra Modi
In what is considered a breakthrough in fertility treatment, scientists at Mumbai's National Institute of Research in Reproductive Health (NIRRH) have patented a sperm-quality test that is simple enough to be developed into a home kit.
The Indian Council of Medical Research (ICMR) has invited bids from private companies to produce it commercially.
The Resazurin Reduction Test (RRT) is more effective in assessing male fertility than the standard semen analysis which cannot evaluate functional competence of sperms. RRT also seeks to replace four advanced and very expensive diagnostic tools that assess sperm count, motility and quality. RRT, its developers hope, can be sold for Rs 100 per kit.
RRT is a dye test involving a coloured compound containing a sodium salt that functions as an oxidation reduction indicator. It is readily reduced — a specific chemical reaction involving transfer of electrons — by motile sperm. The reduction happens faster if the number of such sperms is high. Information from this single test is equal to the data from four advanced tests that take a week and cost about Rs 20,000. Also, these tests are not routinely done in any centre in India.
- Across the aisle: If we kill dissent, we will kill liberty
- Fifth column: Doubting Thomases
- Out of my mind: A dangerous world
- Inside Track: Brilliant minds?
- Pakhtun warlord’s career shows how many forces prop up non-state actor
- Samdhariya’s case points to a society bound together by violence against its children